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1  |  INTRODUC TION
Pharmacology is the study of how medicines and other drugs work 
and are processed by the body.1 As such, pharmacology undergrad-
uates require a comprehensive understanding of both in vitro and in 
vivo drug responses. Despite advances in molecular biologic tech-
niques, studies in isolated cells and tissues do not fully model the 
complex interactions observed in whole organisms. Currently, in vivo 
validation remains critical in the drug discovery and development 
process.2 In order to limit the use of animal models at this preclinic 
stage, the principles of replacement, reduction, and refinement, the 
3Rs,3 aims to address the potential harms to animals while support-
ing high- quality science and translation by addressing the benefits 
of this research.4
Animal use in pharmacology education has steadily declined in 
the last 30 years, with their use in education and training accounting 
for <1% of in vivo experimental procedures in 20195 and <2% of 
students taught in vivo skills during their degree.6
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Abstract
Pharmacology graduates require an understanding of both in vitro and in vivo drug re-
sponses but there has been a decline in animal use in pharmacology education over the 
last 30 years. To address this, we present the novel invertebrate model, Lumbriculus 
variegatus,	for	in	vivo	testing	of	drugs	in	a	teaching	environment.	We	have	developed	
two novel behavioral assays: the stereotypical movement assay, which measures the 
effect of drugs on the ability of L. variegatus to perform stereotypical movements 
following tactile stimulation, and the free locomotion assay, which measures drug ef-
fects	on	unstimulated	movement.	We	report	the	effects	of	compounds	with	diverse	
pharmacodynamic properties on L. variegatus using these assays. The ryanodine re-
ceptor antagonist, dantrolene, altered the unstimulated movement of L. variegatus at 
5 μM,	whereas	stimulated	movement	was	inhibited	at	≥25	μM. Lidocaine, a voltage- 
gated sodium channel blocker, and quinine, a nonselective sodium and potassium 
channel blocker, reduced both stimulated and unstimulated L. variegatus movement 
at	≥0.5	mM.	Inhibitory	effects	of	quinine	persisted	for	up	to	24	h	after	drug	removal,	
whereas lidocaine effects were reduced 10 min after drug removal. Herein, we pro-
vide proof- of- concept utilization of L. variegatus as an organism for use in in vivo phar-
macology education but without regulatory constraints or the need for specialized 
equipment and training.
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2 of 10  |     SEELEY Et aL.
Learned societies, such as the British Pharmacologic Society, 
have highlighted the importance of these skills through inclusion in 
recommended curricula within pharmacology education.7,8 Despite 
significant financial contributions from these societies and the phar-
maceutical industry, in vivo skills remain an area of concern.9- 12
We	present	a	novel	invertebrate	model,	Lumbriculus variegatus, for 
use in whole- organism studies in a teaching environment. Excluding 
any living cephalopod, invertebrates are not covered under the Animal 
(Scientific	Procedures)	Act	1986,	and	this	organism,	therefore,	offers	
the opportunity for utilization within pharmacology education.
L. variegatus is an aquatic worm inhabiting shallow freshwater 
ponds, lakes, and marshes,13 and these animals have been exten-
sively characterized as indicator organisms for toxic compounds in 
aquatic systems.14- 19 Touching the anterior of L. variegatus results 
in retraction and the reversal of body position, whereas touching 
the tail elicits helical swimming.13 These behaviors have previously 
been described and used to determine the effects of exogenous 
compounds on L. variegatus.13,14,20 Despite the previous works of 
literatures on ecological toxicology, much less is known about L. var-
iegatus reaction to drug compounds.21,22
L. variegatus enables the inclusion of practical in vivo pharmacol-
ogy experiments to improve student learning and confidence within 
the laboratory as well as training in in vivo pharmacology. This or-
ganism is low- cost and exempt from much of the regulation and eth-
ical challenges associated with conventional in vivo models, which 
often prevent in vivo practical classes.6,23
Using	novel	assays	which	have	been	developed	to	be	easily	trans-
ferred for inclusion within the education setting, we present the 
effects of three distinct ion channel blockers on the behavior of L. 
variegatus. Specifically, the ability to perform the stereotypical behav-
iors of body reversal and helical swimming following tactile stimula-
tion and unstimulated free locomotion, in the presence of dantrolene, 
a ryanodine receptor antagonist,24 lidocaine, a voltage- gated sodium 
channel blocker,25 and quinine, a nonselective sodium and potas-
sium channel blocker.26 Our aim was to develop a novel whole animal 
model for use within a teaching environment for the demonstration 
of fundamental pharmacologic principles and techniques. This was 
tested in a first- year medical pharmacology laboratory practical, and 
anecdotal feedback collected, alongside experimental data.
We	found	that	L. variegatus is a technically straightforward yet 
effective animal model for the teaching of in vivo pharmacology. 
Additionally, this organism has broader potential in pharmacologic 
education, analogous to Caenorhabditis elegans and Drosophila 
melanogaster.
2  |  METHODS
2.1  |  Lumbriculus variegatus culture
L. variegatus were purchased from Alfa Fish Foods and laboratory- 
reared in aquariums containing artificial pondwater, composed as 
previously described by O’Gara et al.,14	using	UV-	treated	deionized	
water	produced	by	Elix®	Essential	3	UV	Water	Purification	System.	
The artificial pondwater was continuously aerated and water filtered 
using commercial air stones and aquarium filters, respectively. The 
pH was not monitored or adjusted once the worms were placed in 
the	water.	The	aquariums	were	kept	at	room	temperature	(18–	21°C)	
and subject to a 16:8- h light- dark cycle. Cultures were fed TetraMin 
flakes and 10 mg/L spirulina weekly.
L. variegatus populations were maintained for a minimum of 
3 months before experimentation to limit variation in the colony. 
Individual worms used in experiments were randomly selected, 
lacked any obvious morphological defects, and ranged from 2 to 
8 cm in length as per previous studies14 as we observed no size- 
dependent changes within this range.
2.2  |  Reagents and solutions
Dantrolene, lidocaine, and quinine were obtained from Sigma- Aldrich 
(Dorset,	United	Kingdom).	Dantrolene	and	quinine	were	dissolved	in	
100%	dimethyl	sulfoxide	(DMSO)	(Sigma-	Aldrich)	for	a	stock	solution	
concentration of 10 mM and 200 mM, respectively. Dantrolene and 
quinine were diluted in artificial pondwater to give a final DMSO con-
centration of 0.5% and a maximum final concentration of 50 μM and 
1 mM, respectively. Artificial pondwater with 0.5% DMSO was used 
as a vehicle control for dantrolene and quinine experiments. Lidocaine 
was dissolved in artificial pondwater to give a maximum of 1 mM final 
concentration and artificial pondwater was used as the vehicle control.
2.3  |  Stereotypical movement assay
Eighteen to 24 h before experimentation, one L. variegatus worm was 
placed	in	each	well	of	a	Cellstar®	6-	well	plate	(Greiner	Bio-	One)	con-
taining 4 ml of artificial pondwater. Plates were kept at room tempera-
ture and subject to a 16:8- h light- dark. After this acclimation period, 
the pondwater was replaced and the baseline ability of the worm to 
perform	stereotypical	behaviors	was	 tested	and	 recorded	 (Baseline).	
This was done by alternately stimulating the anterior or posterior ends 
of the body with a clean 20– 200 μl plastic pipette tip, 5 times per end, 
with a 5– 10- s interval between stimuli. Movement was scored as 1 = no 
movement, 2 = incomplete stereotypical movement, 3 = full stereo-
typical movement. The artificial pondwater was then removed and im-
mediately replaced with a drug or a vehicle (artificial pondwater only or 
0.5%	DMSO	in	artificial	pondwater)	was	added.	After	a	10-	min	incuba-
tion with a drug solution or vehicle, the worms were tested again using 
the	same	procedure	(drug	exposure).	For	the	“rescue”	experiments,	the	
drug solution or vehicle was aspirated from the well, and to remove any 
latent drug or vehicle residue, fresh pondwater was added and then 
immediately aspirated and then replaced with fresh, untreated pond-
water.	These	worms	were	then	retested	at	10	min	(Rescue	10	mins)	and	
24	h	(Rescue	24	h)	postdrug	or	vehicle	treatment.	Data	are	expressed	
as a ratio of the movement score while in treatment relative to baseline. 
The data collection methods for these assays are shown in Figure 1.
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2.4  |  Free locomotion assays
As in the stereotypical movement assay, 18– 24 h before testing, 
worms were placed individually in Cellstar® 6- well plates with fresh 
pondwater and kept at room temperature and subject to a 16:8- h 
light- dark. Following this acclimation period, pondwater was re-
placed with 2 ml fresh artificial pondwater to limit movement in 
the z- axis, and baseline free locomotion was recorded by rapid, se-
quential image collection with a 13- megapixel camera at a rate of 
one image per second for 50 s. Images were then collected 10 min 
after removing and immediately replacing artificial pondwater wip-
erth a drug solution or vehicle. Drug solutions and vehicle controls 
were then removed, the wells washed, and fresh pondwater added. 
Rescue	experiments	were	collected	at	10	min	(Rescue	10	mins)	and	
24	h	(Rescue	24	h)	after	drug	or	vehicle	removal.
Collected	 images	were	analyzed	using	 ImageJ	 software.	These	
images were compiled into a z- stack image, this being a compilation 
of photographs taken at 1- s intervals over 50 s. An area of known 
distance	within	each	z-	stack	 image	was	measured	and	 ImageJ	cal-
ibrated	 to	 pixels	 per	 centimeter	 (pixels/cm)	within	 each	 image.	 To	
determine the area traversed by each worm, the foreground and 
background were separated using the thresholding functionality of 
ImageJ	to	separate	the	pixels	activated	by	L. variegatus from those 
activated by the 6- well plate. The total area covered by the L. var-
iegatus at baseline, drug exposure, Rescue 10 min, and Rescue 24 h 
was then determined based on the calibration of pixels/cm within 
ImageJ.	Data	are	expressed	as	a	percentage	of	the	area	covered	by	L. 
variegatus in baseline conditions. The data collection method for this 
assay is shown in Figure 2.
For both assays and as per previous studies that have used 
L. variegatus,14 decompositions, as determined by visible tissue 
degeneration and whole- organism tissue pallor, at assay endpoints 
was the main indicator of lethal toxicity. L. variegatus were only ex-
posed to one test compound and euthanized at assay endpoints by 
rapid submersion in 70% ethanol.
2.5  |  Statistical analysis
The sample size for each assay and treatment was eight worms. Data 
are displayed as the mean ±	standard	error	of	the	mean	(SEM)	for	each	
data set. Data are relative to the untreated, baseline control condi-
tion.	 Values	 for	 each	 behavioral	measurement	were	 compared	with	
the	untreated	control	conditions	 (baseline)	 for	each	L. variegatus per 
condition. Statistical analysis was performed in GraphPad Prism 9. 
Drug exposure conditions were compared with baseline conditions by 
paired nonparametric two- tailed t test for stereotypical movement as-
says and paired parametric two- tailed t test for free locomotion assays. 
A	two-	way	ANOVA	with	Dunnett's	posttest	was	used	to	analyze	10-	
min and 24- h rescue time points compared with baseline conditions 
for both assays. p < .05 was the threshold for statistical significance.
3  |  RESULTS
3.1  |  Behavioral response to dantrolene
The ryanodine receptor antagonist, dantrolene,24 had no significant 
effects	on	stereotypical	movements	at	≤25	µM. However, we found 
that 50 µM minimally but significantly inhibited body reversal after 
10 min exposure (p =	 .0313,	Figure	3A).	This	was	not	 the	case	 for	
helical swimming (p >	.05,	Figure	3B).	Ten	min	after	removal	of	50	µM 
F I G U R E  1 Measuring	stereotypical	movement	of	Lumbriculus variegatus.	(A)	L. variegatus are plated in 6- well plates 18– 24 h before the 
experiment begins. L. variegatus are alternately stimulated with 20– 200 μl	pipette	tip	at	the	(B)	anterior	region	(shown	in	gray),	to	stimulate	
body	reversal,	or	(C)	posterior	region	(shown	in	black),	to	stimulate	helical	swimming.	Worms	are	stimulated	for	a	total	of	5	times/end,	
with	a	5–	10-	s	interval	between	stimuli.	(D)	These	movements	are	objectively	scored	and	recorded	as	1	= no movement, 2 = incomplete 
stereotypical movement, 3 = full stereotypical movement, as previously described by Drewes.13	(A–	D)	is	repeated	for	each	L. variegatus 
before exposure to drug compounds to give the baseline ability to perform these movements. L. variegatus are then tested again 10 min after 
incubation with drugs and 10 min and 24 h in artificial pondwater only. Data are expressed as a ratio of the movement score after exposure 
relative to the baseline movement score
4 of 10  |     SEELEY Et aL.
dantrolene and incubation in artificial pondwater, body reversal was 
significantly reduced compared with baseline (p =	.0121,	Figure	3C).	
We	also	observed	that	helical	swimming	movements	were	reduced	
10 min after the removal of 25 µM (p =	.0088,	Figure	3D)	and	50	µM 
dantrolene (p =	.0081,	Figure	3D).	These	effects	persisted	for	24-	h	
after exposure to both 25 µM (p =	.0290,	Figure	3D)	and	50	µM dan-
trolene (p =	.0015,	Figure	3D)	but	were	only	observed	for	the	helical	
swimming and not body reversal. Despite this prolonged effect on 
movement, at 24 h, the worms were still alive with no signs of tissue 
decomposition.
The helical swimming and body reversal assays rely on tactile 
stimulation by an observer. In addition to stimulated behaviors, 
we also wanted to determine if unstimulated free locomotion was 
affected by our test compounds. Figure 3E– G shows that for dan-
trolene, we observed no significant differences between baseline 
free	locomotion	and	drug	treatment	(Figure	3F	and	G)	except	for	
5 µM. This treatment significantly increased free locomotion by 
18.30 ± 10.85% compared with baseline (p = .0341, Figure 3E and 
F).
3.2  |  Behavioral response to lidocaine
As shown in Figure 4A and B, we found that the sodium channel 
blocker lidocaine significantly inhibited both body reversal and heli-
cal	 swimming	 at	 0.5	mM	and	 1	mM.	At	 concentrations	 ≤0.5	mM,	
these effects were reversed following 10 min in drug- free artificial 
pondwater, with no significant difference compared with baseline 
(p >	 .05,	Figure	4C	and	D).	However,	the	effect	of	1	mM	lidocaine	
persisted 10 min after removal, significantly inhibiting both body 
reversal (p =	 .0115,	 Figure	 4C)	 and	 helical	 swimming	 (p = .0035, 
Figure	4D).	Twenty-	four	hours	after	lidocaine	exposure,	both	move-
ments returned to baseline levels (p >	.05,	Figure	4C-	D).
We	 also	 observed	 these	 dose-	dependent	 effects	 in	 the	 free	
locomotion	assays	(Figure	4E-	G),	where	the	movement	was	signifi-
cantly reduced at 0.5 mM (76.24 ±	5.23%)	and	1mM	(85.92	±	5.23%)	
lidocaine compared with baseline levels (p <	 .0001,	 Figure	 4F).	
Similar to the stereotypical movement assay, movement returned to 
baseline levels at both 10 min and 24 h after drug exposure(p > .05, 
Figure	4G).
F I G U R E  2 Measuring	free	locomotion	of	Lumbriculus variegatus.	(A)	L. variegatus are plated in 6- well plates 18– 24 h before the experiment 
begins.	(B)	50	images	are	then	collected	at	1-	s	intervals.	(C)	Images	are	then	arranged	into	a	z- stack and scale is set to an area of known 
distance	within	the	z-	stack.	(D)	Each	individual	L. variegatus	is	isolated	using	freehand	selection	and	(E)	isolated	from	the	remaining	image.	(F)	
Thresholds are then set to only select L. variegatus	and	background	is	then	removed.	(G)	The	total	area	covered	by	each	L. variegatus can then 
be	calculated	using	the	set	scale	and	(H)	graphed	for	presentation	and	analysis.	(A–	F)	is	repeated	for	each	L. variegatus to give the baseline 
movement before exposure to drug compounds, 10 min after incubation with drugs and 10 min and 24 h in artificial pondwater only. Data 
are expressed as a percentage of baseline controls







bars represent the standard error of the mean, n =	8	for	each	concentration.	Veh:	0.5%	DMSO	in	artificial	pondwater.	*/#	p <	.05,	**/##	
p <	.01;	where	*	refers	to	statistical	significance	between	baseline	and	dantrolene	exposure	or	statistical	significance	between	baseline	and	
rescue	10	mins,	#	refers	to	statistical	significance	between	baseline	and	rescue	24	h
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3.3  |  Behavioral response to quinine
Following on from lidocaine, we sought to examine the effect of a 
different ion channel blocker on L. variegatus. Figure 5A- B shows 
that the nonspecific sodium and potassium channel blocker quinine 
inhibited both body reversal and helical swimming at equimolar 
concentrations	 to	 lidocaine	 (0.5	mM	and	1	mM).	However,	 unlike	
lidocaine, these effects persisted after 10 min and 24 h in drug- free 
artificial (p <	.0001,	Figure	5C-	D).
We	 observed	 similar	 results	 in	 the	 free	 locomotion	 assay	
(Figure	5E-	G).	Movement	 increased	by	45.5±7.70% after exposure 
to 0.01 mM quinine (p =	.0006,	Figure	5F),	however,	this	effect	was	
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F I G U R E  4 The	effect	of	lidocaine	on	Lumbriculus variegatus behavior. L. variegatus	were	exposed	to	lidocaine	(0–	1	mM)	and	tested	for	the	





removal of lidocaine for 10 min and 24 h are expressed as a percentage of the area covered at baseline. Error bars represent the standard 
error of the mean, n =	8	for	each	concentration.	Veh:	Artificial	pondwater.	*p <	.05,	**p <	.01,	***p <	.001,	****p < .0001
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reversed and returned to baseline conditions after 10 min and 24 h in 
drug- free artificial pondwater (p >	.05,	Figure	5G).	Conversely,	free	
locomotion was inhibited by 52.59 ± 4.04% at 0.5 mM (p < .0001, 
Figure	5F)	and	90.15	± 1.67% at 1 mM concentrations (p < .0001, 
Figure	 5F).	 This	 inhibitory	 effect	 persisted	 after	 10	 min	 in	 drug-	
free artificial pondwater with 0.5 mM inhibiting movement by 
32.68 ± 5.51% (p =	.0112,	Figure	5G)	and	by	83.04	± 2.98% at 1 mM 
(p <	.0001,	Figure	5G)	as	well	as	after	24	h	(p <	.0001,	Figure	5G).	
At	 this	point,	 as	with	dantrolene	 (Figure	3),	despite	 the	prolonged	
effect on movement, the worms were alive with no signs of tissue 
decomposition.
4  |  DISCUSSION
L. variegatus has been extensively characterized as indicator organisms 
for toxic compounds in aquatic systems and proposed as a standard 
organism for sediment bioaccumulation tests.14- 19,27 Herein, we dem-
onstrated that L. variegatus has application as an effective model for 
the teaching of the effects of pharmacological agents on an intact sys-
tem.	Using	two	novel	assays,	we	describe	three	different	behavioral	
endpoints, body reversal, helical swimming, and free locomotion, that 
can be measured without the need for costly or specialized equipment, 
regulatory approval, or highly specialized animal housing facilities— 
requirements that often prevent the teaching of in vivo practical 
skills.6,23	We	recognize	 that	experiments	conducted	 in	 invertebrates	
do not replicate the complexity of higher animals and experiments 
conducted in invertebrates do not wholly replace studies in vertebrate 
species, such as mice and rats. However, grounding students in ex-
perience with L. variegatus will provide many of them with the whole 
animal experience they otherwise would not have while providing an 
excellent foundation experience for those who will go on to research 
higher organisms. Experience with this organism exposes students to 
concepts around replacement, refinement, and reduction3 in animal 
experimentation but also gives them the direct experimental experi-
ence of putting these elements into practice.
There are other invertebrate models available for use in pharma-
cology and biomedical sciences teaching: C.elegans, D. melanogaster, 
and others.28 However, in the classroom laboratory, L. variegatus 
presents some advantages over these organisms. First, the larger 
size of L. variegatus	 (50–	80	mm)	compared	with	C. elegans (~1	mm)	
makes it easier to view as an individual.29,30 Second, for the assays 
presented, the drug exposure time and rescue time points have been 
demonstrated to be sufficient for several compounds tested to elicit 
effects and enable educators to complete these experiments within 
a standard laboratory practical teaching timeframe. Moreover, when 
implemented within first- year undergraduate toxicology teaching, 
students	 have	 reported	 that	 these	 assays	 “[were]	 really	 helpful	 in	
helping	me	understand	our	course	content,”	 they	“made	you	think	
like	a	scientist”	and	that	they	were	“stimulating	and	enjoyable.”
In	 the	 stereotypical	 movement	 assay	 (Figure	 1),	 students	 can	
measure the effects of drugs on reducing two different behav-
iors	 (body	 reversal	 and	 helical	 swimming)	 without	 the	 need	 for	
a microscope or a specialist equipment, unlike other models used 
in teaching such as C. elegans.31 This assay allows students to dis-
tinguish L. variegatus that do not perform body reversal or helical 
swimming movements from worms that do— giving them hands- on 
semi- quantitative in vivo pharmacology training. The relative ease of 
the tactile stimulation application and the simplicity of the scoring 
system minimize the risk of misinterpretation of the movements and 
limit any variation between students conducting the assay. The free 
locomotion assay is a more sophisticated and quantitative experi-
ment, which allows students to engage in movement recording and 
quantitative analysis.
Both assays offer educators the opportunity to use these exper-
iments to engage students with in vivo measurement and scoring, 
data recording and interpretation, and statistical analysis. There is 
also excellent potential for introducing other key curriculum con-
cepts such as experimental blinding, molarity calculations, drug solu-
bility, and toxicology. Further assay development may yield practical 
teaching protocols for behavioral assays such as tolerance and place 
preference, in vitro assays such as receptor binding and immunohis-
tochemistry, and drug dose– response relationship for other physio-
logical measurements, for example, pulse rate.32
No in vivo model is without limitations. One constraint in study-
ing aquatic organisms is tested compound solubility. Our ability to 
investigate dantrolene was limited due to its known solubility and 
precipitation issues.24,33 As such, 50 µM was the maximal concentra-
tion	achieved	using	DMSO	(0.5%)	 in	artificial	pondwater.	Similarly,	
lidocaine and quinine were used at maximal concentrations dictated 
by	their	solubility.	Additionally,	it	should	be	noted	that	DMSO	(0.5%)	
as a vehicle produced no significant changes in worm behavior com-
pared	with	baseline	(Figures	3	and	5).	Further	investigation	into	drug	
compound solubility and the effects of different vehicles on these 
worms are needed to fully identify the limitations of this specific 
model.
The differential acute and long- term effects of dantrolene, li-
docaine, and quinine on L. variegatus behavior suggest that these 
drugs are working through distinct mechanisms. It is not known if 
this species expresses the sites of action for their respective mech-
anisms of action. Currently, this is limited is by the current lack 
of genomic information on L. variegatus; it is full genome has not 
been sequenced and protein expression studies are limited.34 This 
lack of knowledge presents both limitations and opportunities for 
further pharmacological investigation of these animals. For exam-
ple, in our study, dantrolene did not demonstrate a straightforward 
dose- dependent effect on L. variegatus stereotypical movements 
(Figure	 3A–	D)	 or	 free	 locomotion	 (Figure	 3E–	G).	 The	 5	 µM pro-
duced locomotor activation while higher concentrations did not. 
This variable response may be due to a lack, or the alteration, of 
the dantrolene binding site within ryanodine receptors or their 
homologs. It may also be differential absorption, distribution, 
metabolism, and excretion of pharmacological compounds that 
may account for the varying results observed here. Studies have 
demonstrated that L. variegatus express the ATP- binding cassette 
transporter protein, p- glycoprotein,35 but further study is required 
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to dissect the applicability of pharmacokinetics within L. variegatus 
to pharmacological studies.
Lidocaine and quinine, however, demonstrated clear 
dose- dependent effects on both stereotypical movements 
(Figures	 4A–	D	 and	 5A–	D,)	 and	 free	 locomotion	 (Figures	 4E–	G	
and	 5E–	G)	 at	 0.5–	1	mM.	 Interestingly,	 quinine	 demonstrated	 a	
45.5±7.70% increase in free locomotion at 0.01 mM (p = .0006, 
Figure	5F)	and	then	effects	became	inhibitory.	This	may	be	due	
to off- target toxicity at concentrations >0.1 mM. Throughout 
our assays, we observed no evidence of decomposition of L. 
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variegatus 24 h after drug exposure, indicating that doses used 
were sublethal.
While	we	 have	 shown	 that	 these	 compounds	 induce	 differen-
tial pharmacodynamic effects with lidocaine being readily reversible 
and quinine having long term, but sublethal, further study is required 
to elucidate the full pharmacokinetic and pharmacodynamic profile 
of this species.
L. variegatus, and the novel assays we present, will emphasize 
to students the use and importance of animals in pharmacological 
research and drug development while giving them hands- on ex-
perience in a living system. The purpose of our study was not to 
provide a full evaluation of the resource by students but anecdotal 
comments and feedback from them indicate that they enjoy using 
the worms and they recognize the practical skills they have gained 
in doing so. It is important to ensure that pharmacology students 
continue to receive training in in vivo pharmacology at a time when 
few students currently do.6 Educators must seek to address the 
skills gap and prepare successful graduates9- 12— both for our stu-
dents’ benefit and for the continued advancement of the pharma-
cology discipline.
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